Medical Letter on Drugs and Therapeutics
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.1 | Q4 | 12.6% | 0.257 | Q3 | 37.8% |
| 2024 | 1.4 | Q4 | 21.0% | 0.199 | Q3 | 30.7% |
| 2023 | 1.4 | Q4 | 24.0% | 0.239 | Q3 | 41.3% |
| 2022 | 1.9 | Q4 | 29.9% | 0.211 | Q3 | 39.2% |
| 2021 | 1.7 | Q4 | 33.4% | 0.254 | Q3 | 46.4% |
| 2020 | — | — | 0.246 | Q3 | 43.5% | |
| 2019 | — | — | 0.357 | Q3 | 57.7% | |
| 2018 | — | — | 0.577 | Q2 | 69.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1523-2859
ISSN
0025-732X
region
Northern America
coverage
1965-2026